PubRank

Suresh C Tyagi

Author PubWeight™ 171.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012 20.08
2 Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond) 2004 2.13
3 Induction of oxidative stress and disintegrin metalloproteinase in human heart end-stage failure. Am J Physiol Lung Cell Mol Physiol 2002 1.76
4 Mechanism of matrix accumulation and glomerulosclerosis in spontaneously hypertensive rats. J Hypertens 2003 1.71
5 Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol 2005 1.68
6 MicroRNAs as a therapeutic target for cardiovascular diseases. J Cell Mol Med 2009 1.67
7 Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. Cardiovasc Diabetol 2005 1.59
8 Folic acid improves acetylcholine-induced vasoconstriction of coronary vessels isolated from hyperhomocysteinemic mice: an implication to coronary vasospasm. J Cell Physiol 2011 1.54
9 Pioglitazone prevents cardiac remodeling in high-fat, high-calorie-induced Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol 2006 1.50
10 Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy. Cardiovasc Diabetol 2002 1.46
11 Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. Am J Physiol Renal Physiol 2009 1.43
12 Folic acid improves inner ear vascularization in hyperhomocysteinemic mice. Hear Res 2011 1.42
13 Homocysteine causes cerebrovascular leakage in mice. Am J Physiol Heart Circ Physiol 2005 1.35
14 Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice. J Exp Med 2007 1.32
15 H2S protects against methionine-induced oxidative stress in brain endothelial cells. Antioxid Redox Signal 2009 1.30
16 Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy. J Biol Chem 2008 1.28
17 Mitochondrial division/mitophagy inhibitor (Mdivi) ameliorates pressure overload induced heart failure. PLoS One 2012 1.28
18 Hydrogen sulfide mitigates cardiac remodeling during myocardial infarction via improvement of angiogenesis. Int J Biol Sci 2012 1.27
19 H2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure. Am J Physiol Heart Circ Physiol 2009 1.23
20 Regulation of homocysteine-induced MMP-9 by ERK1/2 pathway. Am J Physiol Cell Physiol 2005 1.22
21 Cystathionine-beta-synthase gene transfer and 3-deazaadenosine ameliorate inflammatory response in endothelial cells. Am J Physiol Cell Physiol 2007 1.22
22 Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure. J Appl Physiol (1985) 2011 1.18
23 Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia. Am J Physiol Heart Circ Physiol 2008 1.17
24 Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis. Am J Nephrol 2010 1.16
25 Mechanisms of cardiovascular remodeling in hyperhomocysteinemia. Antioxid Redox Signal 2011 1.16
26 Role of matrix metalloproteinase-9 in endothelial apoptosis in chronic heart failure in mice. J Appl Physiol (1985) 2005 1.14
27 Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia. J Cell Biochem 2006 1.14
28 The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded. Cardiovasc Diabetol 2005 1.14
29 Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats. Am J Physiol Heart Circ Physiol 2002 1.14
30 Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC. Am J Physiol Heart Circ Physiol 2006 1.13
31 MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure. Arch Physiol Biochem 2010 1.12
32 MicroRNAs are involved in homocysteine-induced cardiac remodeling. Cell Biochem Biophys 2009 1.11
33 Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery. Neurochem Int 2008 1.11
34 Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation. Cardiovasc Diabetol 2004 1.11
35 Pioglitazone mitigates renal glomerular vascular changes in high-fat, high-calorie-induced type 2 diabetes mellitus. Am J Physiol Renal Physiol 2006 1.10
36 Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. Am J Hypertens 2002 1.10
37 Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation. Nutr J 2004 1.07
38 Mechanism of constrictive vascular remodeling by homocysteine: role of PPAR. Am J Physiol Cell Physiol 2002 1.06
39 Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure. Am J Physiol Heart Circ Physiol 2005 1.06
40 Early induction of matrix metalloproteinase-9 transduces signaling in human heart end stage failure. J Cell Mol Med 2005 1.06
41 Type 2 diabetes mellitus as a conformational disease. JOP 2005 1.06
42 Homocysteine to hydrogen sulfide or hypertension. Cell Biochem Biophys 2010 1.05
43 Hydrogen sulfide protects against vascular remodeling from endothelial damage. Amino Acids 2010 1.05
44 Predictors and prevention of diabetic cardiomyopathy. Diabetes Metab Syndr Obes 2013 1.05
45 Fibrinogen induces endothelial cell permeability. Mol Cell Biochem 2007 1.05
46 MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNA. Cell Biochem Biophys 2010 1.04
47 Attenuation of oxidative stress and remodeling by cardiac inhibitor of metalloproteinase protein transfer. Circulation 2004 1.04
48 Nutri-epigenetics ameliorates blood-brain barrier damage and neurodegeneration in hyperhomocysteinemia: role of folic acid. J Mol Neurosci 2014 1.03
49 Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia. J Cell Physiol 2008 1.02
50 Functional consequences of the collagen/elastin switch in vascular remodeling in hyperhomocysteinemic wild-type, eNOS-/-, and iNOS-/- mice. Am J Physiol Lung Cell Mol Physiol 2010 1.01
51 GABA receptors ameliorate Hcy-mediated integrin shedding and constrictive collagen remodeling in microvascular endothelial cells. Cell Biochem Biophys 2006 1.00
52 gamma-Aminbuturic acid A receptor mitigates homocysteine-induced endothelial cell permeability. Endothelium 2007 1.00
53 Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance. Am J Physiol Endocrinol Metab 2008 1.00
54 Cardioprotective role of sodium thiosulfate on chronic heart failure by modulating endogenous H2S generation. Pharmacology 2008 1.00
55 Synergy of homocysteine, microRNA, and epigenetics: a novel therapeutic approach for stroke. Mol Neurobiol 2013 1.00
56 Defective homocysteine metabolism: potential implications for skeletal muscle malfunction. Int J Mol Sci 2013 0.99
57 Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia. Am J Physiol Cell Physiol 2012 0.99
58 Mitochondrial mechanism of oxidative stress and systemic hypertension in hyperhomocysteinemia. J Cell Biochem 2005 0.99
59 Mechanisms of endothelial dysfunction with development of type 1 diabetes mellitus: role of insulin and C-peptide. J Cell Biochem 2005 0.99
60 Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita hearts. Cell Biochem Biophys 2014 0.98
61 Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol. Cardiovasc Diabetol 2010 0.98
62 Nitrotyrosinylation, remodeling and endothelial-myocyte uncoupling in iNOS, cystathionine beta synthase (CBS) knockouts and iNOS/CBS double knockout mice. J Cell Biochem 2009 0.98
63 Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling. Pflugers Arch 2014 0.98
64 Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress. Cardiovasc Diabetol 2003 0.98
65 Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy. J Immunol 2011 0.98
66 Hydrogen sulfide mitigates matrix metalloproteinase-9 activity and neurovascular permeability in hyperhomocysteinemic mice. Neurochem Int 2009 0.98
67 Ablation of MMP9 induces survival and differentiation of cardiac stem cells into cardiomyocytes in the heart of diabetics: a role of extracellular matrix. Can J Physiol Pharmacol 2012 0.98
68 Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone. Int J Biol Sci 2007 0.98
69 Fibrinogen-induced endothelin-1 production from endothelial cells. Am J Physiol Cell Physiol 2009 0.97
70 Generation of nitrotyrosine precedes activation of metalloproteinase in myocardium of hyperhomocysteinemic rats. Antioxid Redox Signal 2002 0.97
71 Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway. J Cell Physiol 2009 0.97
72 Lung ischemia-reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactions. Arch Physiol Biochem 2007 0.97
73 Stem cells as a therapeutic target for diabetes. Front Biosci (Landmark Ed) 2010 0.96
74 3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice. Am J Physiol Lung Cell Mol Physiol 2006 0.96
75 Fibrinogen induces alterations of endothelial cell tight junction proteins. J Cell Physiol 2009 0.95
76 Extracellular matrix remodeling in the heart of the homocysteinemic obese rabbit. Am J Hypertens 2005 0.95
77 Peroxisome proliferators compete and ameliorate Hcy-mediated endocardial endothelial cell activation. Am J Physiol Cell Physiol 2002 0.95
78 Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role? PPAR Res 2010 0.94
79 Doxycycline ameliorates ischemic and border-zone remodeling and endothelial dysfunction after myocardial infarction in rats. J Heart Lung Transplant 2004 0.94
80 Homocysteine induces metalloproteinase and shedding of beta-1 integrin in microvessel endothelial cells. J Cell Biochem 2004 0.94
81 Cystathionine β-synthase and cystathionine γ-lyase double gene transfer ameliorate homocysteine-mediated mesangial inflammation through hydrogen sulfide generation. Am J Physiol Cell Physiol 2010 0.94
82 Cardiac specific deletion of N-methyl-d-aspartate receptor 1 ameliorates mtMMP-9 mediated autophagy/mitophagy in hyperhomocysteinemia. J Recept Signal Transduct Res 2010 0.94
83 GABAA receptor agonist mitigates homocysteine-induced cerebrovascular remodeling in knockout mice. Brain Res 2008 0.93
84 Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function. Vasc Health Risk Manag 2010 0.93
85 Remodeling of the left atrium in pacing-induced atrial cardiomyopathy. Mol Cell Biochem 2002 0.93
86 MicroRNA-133a regulates DNA methylation in diabetic cardiomyocytes. Biochem Biophys Res Commun 2012 0.92
87 Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia. Curr Vasc Pharmacol 2008 0.92
88 Fibrinogen-induced increased pial venular permeability in mice. J Cereb Blood Flow Metab 2011 0.90
89 Matrix imbalance by inducing expression of metalloproteinase and oxidative stress in cochlea of hyperhomocysteinemic mice. Mol Cell Biochem 2009 0.90
90 Tetrahydrocurcumin ameliorates homocysteinylated cytochrome-c mediated autophagy in hyperhomocysteinemia mice after cerebral ischemia. J Mol Neurosci 2012 0.90
91 Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus. JOP 2002 0.90
92 GABA receptors and nitric oxide ameliorate constrictive collagen remodeling in hyperhomocysteinemia. J Cell Physiol 2005 0.89
93 Differential regulation of DNA methylation versus histone acetylation in cardiomyocytes during HHcy in vitro and in vivo: an epigenetic mechanism. Physiol Genomics 2014 0.89
94 PPAR gamma agonist normalizes glomerular filtration rate, tissue levels of homocysteine, and attenuates endothelial-myocyte uncoupling in alloxan induced diabetic mice. Int J Biol Sci 2008 0.89
95 Attenuation of beta2-adrenergic receptors and homocysteine metabolic enzymes cause diabetic cardiomyopathy. Biochem Biophys Res Commun 2010 0.89
96 Homocysteine-induced myofibroblast differentiation in mouse aortic endothelial cells. J Cell Physiol 2006 0.89
97 Adaptive-outward and maladaptive-inward arterial remodeling measured by intravascular ultrasound in hyperhomocysteinemia and diabetes. J Cardiovasc Pharmacol Ther 2006 0.89
98 Homocysteine mediated decrease in bone blood flow and remodeling: role of folic acid. J Orthop Res 2011 0.88
99 Matrix metalloproteinase-9 in homocysteine-induced intestinal microvascular endothelial paracellular and transcellular permeability. J Cell Biochem 2012 0.87
100 Autophagy mechanism of right ventricular remodeling in murine model of pulmonary artery constriction. Am J Physiol Heart Circ Physiol 2011 0.87
101 Synergism between AT1 receptor and hyperhomocysteinemia during vascular remodeling. Clin Chem Lab Med 2007 0.87
102 Mutation in collagen gene induces cardiomyopathy in transgenic mice. J Cell Biochem 2002 0.87
103 Ouabain stimulates Na-K-ATPase through a sodium/hydrogen exchanger-1 (NHE-1)-dependent mechanism in human kidney proximal tubule cells. Am J Physiol Renal Physiol 2010 0.87
104 Cardiac matrix: a clue for future therapy. Biochim Biophys Acta 2013 0.87
105 Differential expression of gamma-aminobutyric acid receptor A (GABA(A)) and effects of homocysteine. Clin Chem Lab Med 2007 0.87
106 Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1. Am J Physiol Heart Circ Physiol 2009 0.87
107 Hyperhomocysteinemia decreases bone blood flow. Vasc Health Risk Manag 2011 0.86
108 Isolated low high density lipoprotein-cholesterol (HDL-C): implications of global risk reduction. Case report and systematic scientific review. Cardiovasc Diabetol 2005 0.86
109 Myocardial redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and congestive heart failure. Med Sci Monit 2003 0.86
110 Oxidative mechanism and homeostasis of proteinase/antiproteinase in congestive heart failure. J Mol Cell Cardiol 2006 0.86
111 Matrix Metalloproteinase Inhibition Mitigates Renovascular Remodeling in Salt-Sensitive Hypertension. Physiol Rep 2013 0.85
112 Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia. Int J Physiol Pathophysiol Pharmacol 2011 0.85
113 Hyperhomocysteinemia attenuates angiogenesis through reduction of HIF-1α and PGC-1α levels in muscle fibers during hindlimb ischemia. Am J Physiol Heart Circ Physiol 2014 0.85
114 Hyperhomocysteinemia during aortic aneurysm, a plausible role of epigenetics. Int J Physiol Pathophysiol Pharmacol 2013 0.85
115 The role of homocysteine in bone remodeling. Clin Chem Lab Med 2013 0.85
116 Homocysteine-induced biochemical stress predisposes to cytoskeletal remodeling in stretched endothelial cells. Mol Cell Biochem 2007 0.84
117 Oxidative remodeling in pressure overload induced chronic heart failure. Eur J Heart Fail 2007 0.84
118 Role of PPARgamma, a nuclear hormone receptor in neuroprotection. Indian J Biochem Biophys 2011 0.84
119 Peroxisome proliferator ameliorates endothelial dysfunction in a murine model of hyperhomocysteinemia. Am J Physiol Lung Cell Mol Physiol 2002 0.84
120 Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemia. Arch Physiol Biochem 2006 0.84
121 Elevated level of fibrinogen increases caveolae formation; role of matrix metalloproteinase-9. Cell Biochem Biophys 2014 0.84
122 Reduced alpha adrenergic mediated contraction of renal preglomerular blood vessels as a function of gender and aging. J Cell Biochem 2005 0.83
123 Homocysteine, hydrogen sulfide (H2S) and NMDA-receptor in heart failure. Indian J Biochem Biophys 2009 0.83
124 Role of copper and homocysteine in pressure overload heart failure. Cardiovasc Toxicol 2008 0.83
125 Homocysteine alters cerebral microvascular integrity and causes remodeling by antagonizing GABA-A receptor. Mol Cell Biochem 2012 0.83
126 Homocysteine, brain natriuretic peptide and chronic heart failure: a critical review. Clin Chem Lab Med 2007 0.82
127 Angiotensin-II induced hypertension and renovascular remodelling in tissue inhibitor of metalloproteinase 2 knockout mice. J Hypertens 2013 0.82
128 Differential expression of Gs in a murine model of homocysteinemic heart failure. Vasc Health Risk Manag 2009 0.82
129 Expression of matrix metalloproteinase activity in idiopathic dilated cardiomyopathy: a marker of cardiac dilatation. Mol Cell Biochem 2004 0.82
130 Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease. Cell Biochem Biophys 2014 0.82
131 Folic acid mitigated cardiac dysfunction by normalizing the levels of tissue inhibitor of metalloproteinase and homocysteine-metabolizing enzymes postmyocardial infarction in mice. Am J Physiol Heart Circ Physiol 2010 0.82
132 Dysregulation of Mfn2 and Drp-1 proteins in heart failure. Can J Physiol Pharmacol 2014 0.81
133 Synergism between arrhythmia and hyperhomo-cysteinemia in structural heart disease. Int J Physiol Pathophysiol Pharmacol 2011 0.81
134 Hyperhomocysteinemia and sudden cardiac death: potential arrhythmogenic mechanisms. Curr Vasc Pharmacol 2010 0.81
135 Hydrogen sulfide and sodium nitroprusside compete to activate/deactivate MMPs in bone tissue homogenates. Vasc Health Risk Manag 2013 0.81
136 Exercise mitigates homocysteine - β2-adrenergic receptor interactions to ameliorate contractile dysfunction in diabetes. Int J Physiol Pathophysiol Pharmacol 2011 0.80
137 Congenic expression of tissue inhibitor of metalloproteinase in Dahl-salt sensitive hypertensive rats is associated with reduced LV hypertrophy. Arch Physiol Biochem 2008 0.80
138 Electrical stimulation of cardiomyocytes activates mitochondrial matrix metalloproteinase causing electrical remodeling. Biochem Biophys Res Commun 2010 0.80
139 Renal mitochondrial damage and protein modification in type-2 diabetes. Acta Diabetol 2008 0.80
140 Cardiac stem cell niche, MMP9, and culture and differentiation of embryonic stem cells. Methods Mol Biol 2013 0.79
141 Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice. Metab Brain Dis 2014 0.79
142 Exercise mitigates the adverse effects of hyperhomocysteinemia on macrophages, MMP-9, skeletal muscle, and white adipocytes. Can J Physiol Pharmacol 2014 0.79
143 Neural redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic neuropathy. Med Sci Monit 2004 0.79
144 Chronic hyperhomocysteinemia causes vascular remodelling by instigating vein phenotype in artery. Arch Physiol Biochem 2011 0.78
145 Homocysteine-dependent cardiac remodeling and endothelial-myocyte coupling in a 2 kidney, 1 clip Goldblatt hypertension mouse model. Can J Physiol Pharmacol 2005 0.78
146 Mitochondrial mitophagy in mesenteric artery remodeling in hyperhomocysteinemia. Physiol Rep 2014 0.78
147 Autophagy and heart failure: a possible role for homocysteine. Cell Biochem Biophys 2012 0.77
148 Mitochondrial epigenetics in bone remodeling during hyperhomocysteinemia. Mol Cell Biochem 2014 0.77
149 Mitochondrial mitophagic mechanisms of myocardial matrix metabolism and remodelling. Arch Physiol Biochem 2011 0.77
150 Peroxisome proliferator ameliorates endocardial endothelial and muscarinic dysfunction in spontaneously hypertensive rats. Antioxid Redox Signal 2004 0.76
151 Matrix metalloproteinase in left ventricular remodeling and heart failure. Curr Cardiol Rep 2003 0.76
152 Remodeling in vein expresses arterial phenotype in hyperhomocysteinemia. Int J Physiol Pathophysiol Pharmacol 2011 0.76
153 Tyrosine kinase receptor alteration of renal vasoconstriction in rats is sex- and age-related. Can J Physiol Pharmacol 2012 0.76
154 Cardiac dys-synchronization and arrhythmia in hyperhomocysteinemia. Curr Neurovasc Res 2007 0.75
155 Echocardiography predicts adverse cardiac remodelling in heart failure. Exp Clin Cardiol 2004 0.75
156 Epigenetic revival of a dead cardiomyocyte through mitochondrial interventions. Biomol Concepts 2015 0.75
157 MMP-9 gene ablation mitigates hyperhomocystenemia-induced cognition and hearing dysfunction. Mol Biol Rep 2014 0.75
158 Cardiac synchronous and dys-synchronous remodeling in diabetes mellitus. Antioxid Redox Signal 2007 0.75
159 Ablation of Toll-like receptor 4 mitigates central blood pressure response during hyperhomocysteinemia. J Hypertens 2017 0.75